EUVIMEDEUVIMED entdecken
Crossref

Quantitative spatial profiling of PD-1/PD-L1 and TIGIT/CD155 interaction indicates poor survival outcome and resistance to adjuvant chemotherapy in pancreatic adenosquamous carcinoma

Xianlong Chen, Shanyue Sun, Shuofeng Li, Shuangni Yu, Jie Chen, Xinyuan Chen, Xiaohua Shi, Zhiyong Liang

European Journal of Cancer · 2026-01 · 232 · 116159

DOI: 10.1016/j.ejca.2025.116159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-01. Verfasst von Xianlong Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, PR China…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Receptors, Immunologic, Pancreatic Neoplasms, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Science Foundation of Beijing Municipality, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenReceptors, ImmunologicPancreatic NeoplasmsProgrammed Cell Death 1 ReceptorCarcinoma, AdenosquamousReceptors, VirusDrug Resistance, NeoplasmHumansMaleFemaleChemotherapy, AdjuvantMiddle AgedAgedTumor MicroenvironmentBiomarkers, TumorAdultPrognosisTreatment Outcome

Stichwörter der Autor:innen

Adjuvant chemotherapyCo-localizationMultiple immunohistochemistryPD-L1Pancreatic adenosquamous carcinomaPrognosisTIGIT

Substanzen

B7-H1 AntigenReceptors, ImmunologicTIGIT protein, humanCD274 protein, humanProgrammed Cell Death 1 Receptorpoliovirus receptorPDCD1 protein, humanReceptors, VirusBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, PR China; Key Laboratory of Research in Pancreatic Tumor, Chinese Academy of M…
  • Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, PR China.
  • Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, PR China.

Förderung

  • Natural Science Foundation of Beijing Municipality
  • Peking Union Medical College Hospital
  • Chinese Academy of Medical Sciences

Zitieren

APA

Chen, X., Sun, S., Li, S., Yu, S., Chen, J., Chen, X., Shi, X., & Liang, Z. (2026). Quantitative spatial profiling of PD-1/PD-L1 and TIGIT/CD155 interaction indicates poor survival outcome and resistance to adjuvant chemotherapy in pancreatic adenosquamous carcinoma. European Journal of Cancer, 232, 116159. https://doi.org/10.1016/j.ejca.2025.116159

Vancouver

Chen X, Sun S, Li S, Yu S, Chen J, Chen X, et al. Quantitative spatial profiling of PD-1/PD-L1 and TIGIT/CD155 interaction indicates poor survival outcome and resistance to adjuvant chemotherapy in pancreatic adenosquamous carcinoma. European Journal of Cancer. 2026;232:116159. doi:10.1016/j.ejca.2025.116159

BibTeX
@article{Chen2026,
  author = {Chen, Xianlong and Sun, Shanyue and Li, Shuofeng and Yu, Shuangni and Chen, Jie and Chen, Xinyuan and Shi, Xiaohua and Liang, Zhiyong},
  title = {Quantitative spatial profiling of PD-1/PD-L1 and TIGIT/CD155 interaction indicates poor survival outcome and resistance to adjuvant chemotherapy in pancreatic adenosquamous carcinoma},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {232},
  pages = {116159},
  doi = {10.1016/j.ejca.2025.116159}
}
Kostenlos starten →